Insider Shareholders with Direct Ownership of Biomea Fusion, Inc. (BMEA)
This section provides a comprehensive overview of the insiders with direct ownership of Biomea Fusion, Inc. (BMEA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Biomea Fusion, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
A2 A Pharmaceuticals, Inc.
> 10% Shareholder |
234,658 | 700,000 | 3,500,000 $14.9 Million | 11 |
Jun 01, 2023
Reduced 1.41%
|
|
Rainer M Erdtmann
President and COO |
0 | 21,000 | 713,027 $3.04 Million | 1 |
Dec 29, 2023
Reduced 1.66%
|
|
Franco Valle
Chief Financial Officer |
42,995 | 0 | 42,995 $183,588 | 9 |
Nov 30, 2024
Added 1.14%
|
| 15,000 | 0 | 15,000 $64,049 | 2 |
Sep 30, 2024
Added 40.0%
|
|
|
Juan Pablo Frias
Chief Medical Officer |
349 | 0 | 349 $1,490 | 1 |
May 31, 2024
Added 50.0%
|